Latest Articles
Advanced Endometrial Cancer Pipeline 2025: FDA Updates, - openPR.com
Advanced Endometrial Cancer Pipeline 2025: FDA Updates, openPR.com
Published: Nov. 18, 2025, 6:59 p.m.
An assisted diagnostic and prognostic model for endometrial cancer using 36 serological markers and clinical variables from 562 patients - Nature
An assisted diagnostic and prognostic model for endometrial cancer using 36 serological markers and clinical variables from 562 patients Nature
Published: Nov. 18, 2025, 2:28 p.m.
The influence of menstrual cycle and endometriosis on endometrial expression of epithelial-to-mesenchymal transition (EMT)-related genes - Reproductive Biology and Endocrinology
The influence of menstrual cycle and endometriosis on endometrial expression of epithelial-to-mesenchymal transition (EMT)-related genes Reproductive Biology and Endocrinology
Published: Nov. 18, 2025, 11:50 a.m.
Endometrial Hypoperfusion: The Missing Link in Refractory Thin Endometrium - Frontiers
Endometrial Hypoperfusion: The Missing Link in Refractory Thin Endometrium Frontiers
Published: Nov. 18, 2025, 12:19 a.m.
The association between metabolic syndrome and incidence of endometrial cancer: a meta-analysis - Diabetology & Metabolic Syndrome
The association between metabolic syndrome and incidence of endometrial cancer: a meta-analysis Diabetology & Metabolic Syndrome
Published: Nov. 17, 2025, 6:01 p.m.
Patients with early Endometrial Cancer who don't undergo Hysterectomy have Higher Mortality: Study - Medical Dialogues
Patients with early Endometrial Cancer who don't undergo Hysterectomy have Higher Mortality: Study Medical Dialogues
Published: Nov. 16, 2025, 4:30 p.m.
Ane Gerda Zahl Eriksson: SENSOR-LIIFE - Advancing Exercise Research in Endometrial Cancer Survivor - Oncodaily
Ane Gerda Zahl Eriksson: SENSOR-LIIFE - Advancing Exercise Research in Endometrial Cancer Survivor Oncodaily
Published: Nov. 16, 2025, 9:57 a.m.
Endometrial Cancer Cure Rate: What Patients Need to Know in 2025 - Oncodaily
Endometrial Cancer Cure Rate: What Patients Need to Know in 2025 Oncodaily
Published: Nov. 16, 2025, 8:17 a.m.
FDA approves Promega’s OncoMate test to guide personalised treatment for endometrial cancer - Indian Pharma Post
FDA approves Promega’s OncoMate test to guide personalised treatment for endometrial cancer Indian Pharma Post
Published: Nov. 14, 2025, 3:26 p.m.
Metabolomics reveals the therapeutic efficacy of liposomal resvida in endometrial cancer through regulating autophagy-related gene expression - Cancer Cell International
Metabolomics reveals the therapeutic efficacy of liposomal resvida in endometrial cancer through regulating autophagy-related gene expression Cancer Cell International
Published: Nov. 14, 2025, 4:25 a.m.
Link copied to clipboard!